4-butyrolactone has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, SA; Fahmy, H; Khalifa, SI; Radwan, MM; Szymanski, PT | 1 |
| Ahmed, SA; Fahmy, H; Khalifa, S; Kuppast, B; Szymanski, PT | 1 |
2 other study(ies) available for 4-butyrolactone and B16 Melanoma
| Article | Year |
|---|---|
Evaluation of the anti-melanoma activities of sarcophine, (+)-7alpha,8beta-dihydroxydeepoxysarcophine and sarcophytolide from the Red Sea soft coral Sarcophyton glaucum.
Topics: 4-Butyrolactone; Animals; Anthozoa; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Diterpenes; Melanoma, Experimental; Mice | 2014 |
Sarcophine-diol, a skin cancer chemopreventive agent, inhibits proliferation and stimulates apoptosis in mouse melanoma B₁₆F₁₀ cell line.
Topics: 4-Butyrolactone; Animals; Anticarcinogenic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase 4; Diterpenes; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Melanoma, Experimental; Mice; Neoplasm Proteins; Poly(ADP-ribose) Polymerases; Skin Neoplasms; STAT3 Transcription Factor | 2012 |